NEWPORT BEACH, Calif., March 18, 2021 /PRNewswire/ — CureDuchenne, a number one international nonprofit centered on discovering and funding a treatment for Duchenne muscular dystrophy, proclaims a webinar to continue educating the Duchenne community about the COVID-19 vaccines. A part of their COVID-19 schooling initiative which launched in January, this webinar will give attention to the particular wants of the Duchenne neighborhood as they relate to COVID-19 vaccination.
CureDuchenne’s follow-up webinar on March 19, 2021 entitled, “March Updates on COVID-19 Vaccines – What the Duchenne Community Needs to Know,” will current latest updates on the three COVID-19 vaccines licensed to be used by the CDC. This webinar occasion will once more characteristic a formidable roster of uncommon illness specialists, plus scientific and medical specialists from American regulatory our bodies:
- Brenda Wong, MD, Director, Duchenne Muscular Dystrophy Heart, UMass
- Masaya Douoguih, MD, MPH, Head of Scientific Improvement and Medical Affairs, Janssen Vaccines and Prevention, Johnson & Johnson
- Karen Remley, MD, MBA, MPH, FAAP, Director, Nationwide Heart on Start Defects and Developmental Disabilities
- Peter Marks, MD, PhD, Director of FDA Heart for Biologics Analysis and Analysis
- William Gruber, MD, Senior Vice President, Vaccine Scientific Analysis and Improvement, Pfizer, Inc.
- Debra Miller, Founder and CEO, CureDuchenne
- Moderator: Michael Kelly, PhD, Chief Scientific Advisor, CureDuchenne
“With this replace from main specialists on COVID vaccines, we’re fulfilling our pledge to coach and help the Duchenne neighborhood with dependable vaccine info,” stated Debra Miller, founder and CEO, CureDuchenne. “Panelists from Pfizer and Johnson & Johnson, the most recent vaccine entrant, will share precisely the type of focused first-hand info our neighborhood deserves and the CureDuchenne workforce strives to supply. A dialogue of the particular wants and anxieties our neighborhood may need will likely be mentioned with trusted allies, Dr. Brenda Wong and Dr. Karen Remley. We are going to proceed advocating on behalf of the Duchenne neighborhood all through your complete vaccine rollout and push to inoculate everybody affected by Duchenne.”
The continued initiative, which prioritizes vaccine schooling, entry and help for the worldwide Duchenne neighborhood, is a sustained effort by CureDuchenne. Along with common help applications and advocacy efforts, the workforce maintains a collection of help instruments with info from trusted sources. Important vaccine updates are offered through CureDuchenne communication channels because the vaccine rollout progresses.
CureDuchenne is acknowledged as a worldwide chief in analysis, affected person care, and innovation for enhancing and lengthening the lives of these with Duchenne muscular dystrophy. Because the main genetic killer of younger boys, Duchenne impacts greater than 300,000 people residing in the present day. CureDuchenne is devoted to discovering and funding a treatment for Duchenne by breaking the normal charitable mould by an revolutionary enterprise philanthropy mannequin that funds groundbreaking analysis, early prognosis, and neighborhood schooling. For extra info on how you can assist increase consciousness and funds wanted for analysis, please go to www.cureduchenne.org.